CATB insider filings

CATABASIS PHARMACEUTICALS INC — 18 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2021-06-10. Screen CATB transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for CATB between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — CATABASIS PHARMACEUTICALS INC

FiledFormInsiderReported transactionsSource
2021-06-104Harshbarger Benjamin — Chief Legal OfficerGrant/award (A): 200,000 (derivative) @ $0EDGAR
2021-06-024Komjathy Andrew — Chief Commercial OfficerGrant/award (A): 600,000 (derivative) @ $0EDGAR
2021-06-024Nichols Andrew John — Chief Scientific OfficerGrant/award (A): 600,000 (derivative) @ $0EDGAR
2021-06-024Callori Fred — DirectorGrant/award (A): 85,000 (derivative) @ $0EDGAR
2021-06-024Violin Jonathan — DirectorGrant/award (A): 85,000 (derivative) @ $0EDGAR
2021-06-024Clauser Noah — Chief Financial OfficerGrant/award (A): 600,000 (derivative) @ $0EDGAR
2021-06-024Beck Joanne T. — DirectorGrant/award (A): 100,000 (derivative) @ $0EDGAR
2021-06-024Milne Jill C. — CEO and President, DirectorGrant/award (A): 1,400,000 (derivative) @ $0EDGAR
2021-06-024Cole Hugh M — DirectorGrant/award (A): 100,000 (derivative) @ $0EDGAR
2021-06-024Harshbarger Benjamin — Senior VP, General CounselGrant/award (A): 400,000 (derivative) @ $0EDGAR
2021-06-024LAPOINTE ANTHONY GREGG — DirectorGrant/award (A): 100,000 (derivative) @ $0EDGAR
2021-06-024BATE KENNETH — DirectorGrant/award (A): 100,000 (derivative) @ $0EDGAR
2021-06-024KISHBAUCH MICHAEL D — DirectorGrant/award (A): 100,000 (derivative) @ $0EDGAR
2021-02-034Callori Fred — DirectorGrant/award (A): 1,617 (derivative) @ $3,009.53EDGAR
2021-02-034PERCEPTIVE ADVISORS LLC — Director, 10% owner
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD — Director, 10% owner
Xontogeny, LLC — Director, 10% owner
Perceptive Xontogeny Venture Fund, LP — Director, 10% owner
EDELMAN JOSEPH — Director, 10% owner
Grant/award (A): 4,851 (derivative) @ $3,009.53 · Grant/award (A): 1,617 (derivative) @ $3,009.53EDGAR
2021-02-014Violin Jonathan — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2021-02-014Callori Fred — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2020-09-214Clauser Noah — Chief Financial OfficerGrant/award (A): 35,000 (derivative) @ $0EDGAR

Recent 8-K events — CATABASIS PHARMACEUTICALS INC

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-01-238-K1.01 — Entry into a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-218-K5.07 — Submission of Matters to a Vote of Security Holders
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2025-12-238-K8.01 — Other EventsEDGAR
2025-11-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-10-148-K1.01 — Entry into a Material Definitive Agreement
2.02 — Results of Operations and Financial Condition
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2025-08-068-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2025-06-128-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
EDGAR
2025-03-118-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-01-138-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2024-12-198-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=CATB returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs